Neutrophil activation, protein oxidation and ceruloplasmin levels in children with Henoch-Schönlein purpura

Pediatric Nephrology

Volumn 22, Issue 8, 2007, Pages 1151-1157

  Ece, Aydin ^a   Kelekçi, Selvi ^a   Hekimoglu, Askin ^a   Kocamaz, Halil ^a   Balik, Hasan ^a   Yolbas, Ilyas ^a   Erel, Ozcan ^b  

^a DICLE UNIVERSITY   (Turkey)

^b HARRAN UNIVERSITY   (Turkey)

Author keywords

Arylesterase; Ceruloplasmin; Henoch Sch nlein purpura; Myeloperoxidase; Oxidative stress; Protein oxidation

Indexed keywords

ARYLESTERASE; BIOLOGICAL MARKER; CARBOXYLESTERASE; CERULOPLASMIN; PEROXIDASE; PROTEIN; THIOL DERIVATIVE;

ANAPHYLACTOID PURPURA; ARTICLE; BLOOD; CASE CONTROL STUDY; CHILD; COMPARATIVE STUDY; FEMALE; HUMAN; LEUKOCYTE ACTIVATION; MALE; METABOLISM; OXIDATION REDUCTION REACTION; OXIDATIVE STRESS; PHYSIOLOGY;

BIOLOGICAL MARKERS; CARBOXYLIC ESTER HYDROLASES; CASE-CONTROL STUDIES; CERULOPLASMIN; CHILD; FEMALE; HUMANS; MALE; NEUTROPHIL ACTIVATION; OXIDATION-REDUCTION; OXIDATIVE STRESS; PEROXIDASE; PROTEINS; PURPURA, SCHOENLEIN-HENOCH; SULFHYDRYL COMPOUNDS;

EID: 34548426149     PISSN: 0931041X     EISSN: 1432198X     Source Type: Journal    
DOI: 10.1007/s00467-007-0475-5     Document Type: Article

References (35)

1. Tizard EJ (1996) Henoch-Schönlein purpura. Arch Dis Child 80:380-383
2. Rostoker G, Rymer JC, Bagnard G, Petit-Phar M, Griuncelli M, Pilatte Y (1998) Imbalances in serum proinflammatory cytokines and their soluble receptors: A putative role in the progression of idiopathic IgA nephropathy (IgAN) and Henoch-Schonlein purpura nephritis, and a potential target of immunoglobulin therapy? Clin Exp Immunol 114:468-476
3. Andreoli SP (1991) Reactive oxygen molecules, oxidant injury and renal disease. Pediatr Nephrol 5:733-742
4. Ece A,AtamerY,Gurkan F, Davutoglu M, BiliciM, TutancM,Gunes A (2005) Paraoxonase, anti-oxidant response and oxidative stress in children with chronic renal failure. Pediatr Nephrol 21:239-245
5. Ece A, Gürkan F, Kervancioglu M, Kocamaz H, Güneş A, Atamer Y, Selek Ş (2006) Oxidative stress, inflammation and early cardiovascular damage in children with chronic renal failure. Pediatr Nephrol 21:545-552
6. Shah SV (1988) Evidence suggesting a role for hydroxyl radical in passive Heymann nephritis in rats. Am J Physiol 254:F337-F344
7. Rahman MA, Emancipator SS, Sedor JR (1988) Hydroxyl radical scavengers ameliorate proteinuria in rat immune complex glomerulonephritis. J Lab Clin Med 112:619-626
8. Turi S, Nemeth I, Torkos A, Saghy L, Varga I, Matkovics B, Nagy J (1997) Oxidative stress and antioxidant defense mechanism in glomerular diseases. Free Radical Biol Med 22:161-168
9. Buyan N, Erbas D, Akkok N, Oz E, Biberoglu G, Hasanoglu E (1998) Role of free oxygen radicals and prostanoids in the pathogenesis of Henoch- Schönlein Purpura. Prostaglandins Leukot Essent Fatty Acids 59:181-184
10. Demircin G, Öner A, Ünver Y, Bülbül M, Erdoǧan Ö (1998) Erythrocyte superoxide dismutase activity and plasma malondialdehyde levels in children with Henoch-Schönlein purpura. Acta Paediatr 87:848-852
11. Erdoǧan Ö, Öner A, Aydin A, Işimer A, Demircin G, Bülbül M (2003) Effect of vitamin E treatment on the oxidative damage occurring in Henoch-Schönlein purpura. Acta Paediatr 92:546-550
12. Hazen SL, Hsu FF, Mueller DM, Crowley JR, Heinecke JW (1996) Human neutrophils employ chlorine gas as an oxidant during phagocytosis. J Clin Invest 98:1283-1289
13. Dalle-Donne I, Rossi R, Giustarini D, Milzani A, Colombo R (2003) Protein carbonyl groups as biomarkers of oxidative stress. Clin Chim Acta 329:23-38
14. Himmelfarb J, McMonagle E, McMenamin E (2000) Plasma protein thiol oxidation and carbonyl formation in chronic renal failure. Kidney Int 58:2571-2578
15. Mackness M, Durrington P, Mackness B (2004) Paraoxonase 1 activity, concentration and genotype in cardiovascular disease. Curr Opin Lipidol 15:399-404
16. Baskin E, Bakkaloǧlu A, Beşbaş N, Hasçelik G, Saatçi Ü, Özen S (2002) Ceruloplasmin levels in antineutrophil cytoplasmic antibody-positive patients. Pediatr Nephrol 17:917-919
17. Giurgea N, Constantinescu MI, Stancui R, Suciu S, Muresan A (2005) Ceruloplasmin-acute-phase reactant or endogenous antioxidant? The case of cardiovascular disease. Med Sci Monit 11: RA48-RA51
18. Mills JA, Michel BA, Bloch DA, Calabrese LH, Hunder GG, Arend WP, Edworthy SM, Fauci AS, Leavitt RY, Lie JT (1990) The American College of Rheumatology, 1990 criteria for the classification of Henoch-Schönlein purpura. Arthritis Rheum 33:1114-1121
19. Erel O (1998) Automated measurement of serum ferroxidase activity. Clin Chem 4:313-319
20. Bradley PP, Priebat DA, Christensen RD, Rothstein G (1982) Measurement of cutaneous inflammation: Estimation of neutrophil content with an enzyme marker. J Invest Dermatol 78:206-209
21. Haagen L, Brock A (1992) A new automated method for phenotyping arylesterase (E.C.3·1·1·2) based upon inhibition of enzymatic hydrolysis of 4-nitrophenyl acetate by phenyl acetate. Eur J Clin Chem Clim Biochem 30:391-395
22. Ellman GL (1959) Tissue sulfhydryl groups. Arch Biochem Biophys 82:70-77
23. Hu ML, Louie S, Cross CE, Motchnik P, Halliwell B (1993) Antioxidant protection against hypochlorous acid in human plasma. J Lab Clin Med 121:257-262
24. Erel O (2005) A new automated colorimetric method for measuring total oxidant status. Clin Biochem 38:1103-1111
25. Srivastava CH, Rado TA, Bauerle D, Broxmeyer HE (1991) Regulation of human bone marrow lactoferrin and myeloperoxidase gene expression by tumor necrosis factor-alpha. J Immunol 46:1014-1019
26. Kaysen GA, Dubin JA, Müller HG, Mitch WE, Levin NW; The HEMO Group (2001) Levels of 1 acid glycoprotein and ceruloplasmin predict future albumin levels in hemodialysis patients. Kidney Int 60:2360-2366
27. Yazici C, Köse K, Çaliş M, Demir M, Kirnap M, Ateş F (2004) Increased advanced oxidation protein products in Behçet's disease: A new activity marker? Br J Dermatol 151:105-111
28. Pullar JM, Vissers MC, Winterbourn CC (2000) Living with a killer: The effects of hypochlorous acid on mammalian cells. IUBMB Life 50:259-266
29. Griffin SV, Chapman PT, Lianos EA, Lockwood CM (1999) The inhibition of myeloperoxidase by ceruloplasmin can be reversed by anti-myeloperoxidase antibodies. Kidney Int 55:917-925
30. Kang JH, Kim SK, Choi SY, Kwon HY, Won MH (2001) Oxidative modification of human ceruloplasmin by peroxyl radicals. Biochem Biophys Acta 1568:30-36
31. Morgan PE, Sturgess AD, Davies MJ (2005) Increased levels of serum protein oxidation and correlation with disease activity in systemic lupus erythematosus. Arthritis Rheum 52:2069-2079
32. Öner A, Tinaztepe K, Erdoǧan Ö (1995) The effect of triple therapy on rapidly progressive type of Henoch-Schönlein nephritis. Pediatr Nephrol 9:6-10
33. Orzechowski A, Ostaszewski P, Wilczak J, Jank M, Balasinska B, Wareski P, Fuller J Jr (2002) Rats with a glucocorticoid induced catabolic state show symptoms of oxidative stress and spleen atrophy: The effects of age and recovery. J Vet Med A Physiol Pathol Clin Med 49:256-263
34. Iuchi T, Akaike M, Mitsui T, Ohshima Y, Shintani Y, Azuma H, Matsumoto T (2003) Glucorticoid excess induces superoxide production in vascular endothelial cells and elicits vascular endothelial dysfunction. Circ Res 92:81-87
35. Ece A, Atamer Y, Gürkan F, Davutoǧlu M, Koçyiǧ it Y, Tutanç M (2005) Paraoxonase, total antioxidant response, and peroxide levels in children with steroid-sensitive nephrotic syndrome. Pediatr Nephrol 20:1279-1284